sgp
| 3:00PM 8/07/2009
Merck & Co., Inc. (MRK) announced today that its shareholders voted by an overwhelming 99 percent to approve a proposed $41 billion merger with Schering-Plough Corp. (SGP). Schering-Plough's shareholders, whose meeting started much later, were also quick to approve the deal with the same...
| 2:30PM 8/04/2009
On Friday, shareholders for Merck & Co., Inc. (MRK) and Schering-Plough Corp. (SGP) set to vote on a $41 billion merger. In the meantime, the two companies appear to be doing some house cleaning.
One of the first orders when such a deal goes through is to shake up top management, with many...
| 1:30PM 6/05/2009
Major drug companies are declining more than the general market today, but none like Merck & Co. (MRK). Merck's shares dropped 2.5 percent on news it won't seek approval this year for its heart-failure drug rolofylline after preliminary results of a Phase III study failed to meet...
| 9:00AM 4/21/2009
Merck & Co. (MRK) reported first-quarter earnings Tuesday morning. The drugmaker posted a 57 percent drop in first-quarter income to $1.43 billion, or 67 cents per share. Excluding items, earnings were 74 cents a share, below consensus estimates of 77 cents a share. Similarly, revenue declined...
| 9:30AM 3/09/2009
It seems like every time we get a Democratic president, Merck (MRK) decides it needs to make a big merger. Last time Merck made a big deal it was 1993 just after Bill Clinton entered the White House. Merck was afraid of politically-driven change in the health care industry -- as well as the...
| 9:00AM 3/09/2009
Merck (MRK) said on Monday that it would acquire Schering-Plough (SGP) for $41.1 billion. Schering-Plough shareholders will receive $23.61 a share, representing a premium of about 34 percent over Schering's Friday's close. The benefits: a bigger pipeline, joint R&D, strategic alliances, and of...
| 7:30AM 3/09/2009
Merck (MRK) said on Monday that it would acquire Schering-Plough (SGP) for $41.1 billion. Schering-Plough shareholders will receive $23.61 (0.5767 shares of Merck at Friday's price and $10.50 in cash) a share, representing a premium of about 34 percent over Schering's Friday's close.
This would...